Verity Asset Management Inc. Has $1.77 Million Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Verity Asset Management Inc. decreased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,685 shares of the exchange traded fund’s stock after selling 404 shares during the quarter. SPDR S&P Biotech ETF makes up about 0.9% of Verity Asset Management Inc.’s holdings, making the stock its 25th biggest position. Verity Asset Management Inc.’s holdings in SPDR S&P Biotech ETF were worth $1,773,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Healthcare of Ontario Pension Plan Trust Fund lifted its stake in shares of SPDR S&P Biotech ETF by 198.6% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after buying an additional 6,138,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd bought a new stake in SPDR S&P Biotech ETF during the third quarter valued at about $141,284,000. Assetmark Inc. grew its holdings in SPDR S&P Biotech ETF by 72,653.0% in the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock valued at $58,223,000 after buying an additional 588,489 shares during the last quarter. Sivik Global Healthcare LLC bought a new position in SPDR S&P Biotech ETF during the third quarter worth $29,640,000. Finally, Mirae Asset Securities USA Inc. raised its position in shares of SPDR S&P Biotech ETF by 50.0% during the third quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after buying an additional 300,000 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $91.42 on Tuesday. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47. The stock has a market cap of $6.97 billion, a PE ratio of 11.47 and a beta of 1.11. The firm has a 50-day simple moving average of $93.11 and a 200 day simple moving average of $96.62.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.